Accure Labs Private Limited — Imatinib Exporter Profile
Indian Pharmaceutical Exporter · #7 for Imatinib · $629.7K export value · DGFT Verified
Accure Labs Private Limited is the #7 Indian exporter of Imatinib with $629.7K in export value and 20 verified shipments. Accure Labs Private Limited holds a 2.2% market share in Imatinib exports across 2 countries. The company exports 9 pharmaceutical products worth $11.1M across 2 therapeutic categories.
Accure Labs Private Limited — Imatinib Export Profile: Buyers & Destinations
Where Does Accure Labs Private Limited Export Imatinib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MOROCCO | $440.8K | 17 | 73.2% |
| ALGERIA | $84.0K | 3 | 14.0% |
| SRI LANKA | $77.0K | 11 | 12.8% |
| BELARUS | $11 | 5 | 0.0% |
Accure Labs Private Limited exports Imatinib to 4 countries. The largest destination is MOROCCO accounting for 73.2% of Accure Labs Private Limited's Imatinib shipments, followed by ALGERIA (14.0%) and SRI LANKA (12.8%). These destinations reflect Accure Labs Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Imatinib from Accure Labs Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BANQUE POPULAIRE B P | MOROCCO | $118.0K | 5 |
| PHARMA ASSOCIATES | SRI LANKA | $77.0K | 11 |
| TO THE ORDER OF | MOROCCO | $67.3K | 2 |
| MINISTERE DE LA DEFENSE NATIONALE | ALGERIA | $55.3K | 2 |
| MINISTERE DE LA DEFENSE NATIONALE PREMIERE REGION MILITAIRE | ALGERIA | $28.7K | 1 |
| CREDIT IMMOBILIER ET | MOROCCO | $24.8K | 1 |
| SUNMOON PHARMA LLC | BELARUS | $11 | 5 |
Accure Labs Private Limited supplies Imatinib to 7 buyers globally. The largest buyer is BANQUE POPULAIRE B P (MOROCCO), followed by PHARMA ASSOCIATES (SRI LANKA) and TO THE ORDER OF (MOROCCO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Imatinib Export Value and How Much Does Accure Labs Private Limited Contribute?
India exported $18.5M worth of Imatinib through 1,726 shipments from 224 suppliers to 119 countries, serving 456 buyers globally. Accure Labs Private Limited contributes $629.7K to this total, accounting for 2.2% of India's Imatinib exports. Accure Labs Private Limited ships Imatinib to 4 countries through 7 buyers.
What Is the Average Shipment Value for Accure Labs Private Limited's Imatinib Exports?
Accure Labs Private Limited's average Imatinib shipment value is $31.5K per consignment, based on 20 shipments totaling $629.7K. The largest destination is MOROCCO (73.2% of Accure Labs Private Limited's Imatinib exports).
How Does Accure Labs Private Limited Compare to Other Indian Imatinib Exporters?
Accure Labs Private Limited ranks #7 among 224 Indian Imatinib exporters with a 2.2% market share. The top 3 exporters are CIPLA LIMITED ($5.2M), EUGIA PHARMA SPECIALITIES LIMITED ($4.1M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($2.9M). Accure Labs Private Limited processed 20 shipments to 2 destination countries.
What Imatinib Formulations Does Accure Labs Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IMATINIB ZENITH 400 PRIVATE IMATINIB TABLETS 400 MG 3 X 10 | $91.5K | 2 |
| IMATINIB ZENITH 400(PVT)-IMATINIB TABLET | $50.0K | 1 |
| IMATINIB ZENITH 400 (PRIVATE)(IMATINIB TABLETS 400 MG (3 X 10) | $50.0K | 1 |
| IMATINIB ZENITH 400 (PRIVATE)(IMATINIB TABLETS 400 MG(3X10))(BOTTLES=NUMBERS) | $50.0K | 1 |
| IMATINIB ZENITH 400 (TENDER)(IMATINIB TABLETS 400 MG(3X10))(BOTTLES=NUMBERS) | $50.0K | 1 |
| IMATINIB CIMP 400 MG (COMP)(MATINICCURE400 MG) | $50.0K | 1 |
| MATINICCURE 400MG IMATINIB CIMP 400MGCOMP-14010 TABLETS | $28.7K | 1 |
| PHARMA PRODUCTS:-IMATINIB ZENITH 400 (PR | $24.9K | 1 |
| IMATINIB ZENITH 400 (PRIVATE)(IMATINIB TABLETS 400 MG(PRIVATE)(BOTTLES=NUMBERS) | $24.8K | 1 |
| PHARMA PRODUCTS:-IMATINIB ZENITH 400 (TE | $18.1K | 1 |
Accure Labs Private Limited exports 29 distinct Imatinib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IMATINIB ZENITH 400 PRIVATE IMATINIB TABLETS 400 MG 3 X 10 with 2 shipments worth $91.5K.
How Does Accure Labs Private Limited Compare to Nearest Imatinib Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | NATCO PHARMA LIMITED | $1.3M | 33 | 9 | $39.7K |
| 6 | INTAS PHARMACEUTICALS LIMITED | $857.6K | 19 | 6 | $45.1K |
| 7 | ACCURE LABS PRIVATE LIMITED ★ | $629.7K | 20 | 2 | $31.5K |
| 8 | HETERO LABS LIMITED | $291.4K | 10 | 2 | $29.1K |
| 9 | INTAS PHARMACEUTICALS LTD | $284.7K | 8 | 5 | $35.6K |
Accure Labs Private Limited ranks #7 among 224 Indian Imatinib exporters. Average shipment value of $31.5K compared to the market average of $82.5K. The closest competitors by value are NATCO PHARMA LIMITED and INTAS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Imatinib Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 314 | 18.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 301 | 17.4% |
| DELHI AIR CARGO ACC (INDEL4) | 235 | 13.6% |
| DELHI AIR | 142 | 8.2% |
| Bombay Air | 123 | 7.1% |
| HYDERABAD AIR | 69 | 4.0% |
| HYDERABAD ACC (INHYD4) | 61 | 3.5% |
| AHEMDABAD AIR | 35 | 2.0% |
What Other Advanced Oncology Products Does Accure Labs Private Limited Export?
Accure Labs Private Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Accure Labs Private Limited's Imatinib Exports
Accure Labs' export operations are influenced by several geopolitical factors. The Israel-Iran conflict has heightened security risks in the Red Sea, leading major shipping lines to impose 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation increases shipping costs for Indian exporters, including Accure Labs, potentially affecting profit margins and delivery timelines. (sgeexport.com)
Conversely, the India-European Union Free Trade Agreement, signed in January 2026, eliminates tariffs on pharmaceuticals, enhancing Accure Labs' competitiveness in the European market. This agreement is expected to boost India's pharmaceutical exports by providing tariff-free access, thereby benefiting companies like Accure Labs. (en.wikipedia.org)
Additionally, the EU's Carbon Border Adjustment Mechanism (CBAM) introduces new compliance requirements for exporters. The Directorate General of Foreign Trade (DGFT) has established a 'CBAM Facilitation Cell' to assist exporters in meeting these standards. Accure Labs must adapt to these regulations to maintain its market position in Europe. (sgeexport.com)
Accure Labs Private Limited — Regulatory Compliance & Quality Standards
Accure Labs has proactively secured multiple international regulatory approvals, including European GMP accreditation in 2018 and Russian GMP certification in 2019. These certifications demonstrate the company's adherence to stringent quality standards, facilitating access to diverse global markets. (indiapharmaoutlook.com)
The evolving regulatory landscape, particularly the EU's CBAM, necessitates continuous compliance efforts. Accure Labs must ensure its manufacturing processes align with these environmental standards to sustain its export activities in the European Union. (sgeexport.com)
About Accure Labs Private Limited
Accure Labs Private Limited exports 9 products worth $11.1M. Beyond Imatinib, top products include Gemcitabine, Oxaliplatin, Paclitaxel, Irinotecan, Carboplatin. View the complete Accure Labs Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Imatinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Imatinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Accure Labs Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 36 individual customs records matching Accure Labs Private Limited exporting Imatinib, covering 29 formulations to 4 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 456+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Imatinib Export Data from Accure Labs Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Accure Labs Private Limited's Imatinib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Accure Labs Private Limited
Full Company Profile →
9 products · $11.1M total trade · 2 categories
Imatinib Stats
Company Overview
Top Products by Accure Labs Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Accure Labs Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Imatinib. For current shipment-level data, contact TransData Nexus.